# Lixte Biotechnology Holdings (LIXT) Stock Price, News & Analysis
Canonical URL: https://biopharmsignal.com/company/LIXT
## Company Profile
- Ticker: LIXT
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: Oncology
## Stock Data
- Close: 7.21 USD
- Market cap: 87175925.76 USD
- Last updated: 2026-07-02
## Business Overview
### PP2A Inhibition in Cancer
LIXTE Biotechnology develops cancer therapies based on inhibition of protein phosphatase 2A. Its lead molecule is intended to sensitize tumors to chemotherapy and immunotherapy rather than function solely as a stand-alone cytotoxic drug.
### LB-100
LB-100 is a first-in-class clinical PP2A inhibitor that has shown tolerability at biologically active doses. Proof-of-concept studies are evaluating combinations in ovarian clear-cell carcinoma, metastatic colorectal cancer and advanced soft-tissue sarcoma.
### Proton-Therapy Technology
Through Liora Technologies Europe, LIXTE is also developing the LiGHT System, an electronically controlled proton-therapy platform. This med-tech program broadens the company beyond drug development into precision radiation treatment.
## Why The Stock Is Moving

Current closing-price context is not available for LIXT.

## Future Catalysts

- Lixte’s catalysts are oncology pipeline updates and any strategic move that clarifies the company’s next step. The market will care about whether there is still a viable clinical path.

## Recent News
- 2026-07-31 12:30 EST — [NOMAD Power Solutions Announces Options Trading Begins on Cboe Options Exchange](https://biopharmsignal.com/news/LIXT/nomad-power-solutions-announces-options-trading-begins-on-cboe-options-exchange-a661a6f0) — Source: Lixte Biotechnology Holdings
- 2026-07-29 12:30 EST — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c) — Source: Lixte Biotechnology Holdings
- 2026-07-15 12:30 EST — [NOMAD Power Solutions Strengthens Subsidiary Executive Leadership](https://biopharmsignal.com/news/LIXT/nomad-power-solutions-strengthens-subsidiary-executive-leadership-694eafe1) — Source: Lixte Biotechnology Holdings
- 2026-07-08 12:30 EST — [NOMAD Increases Voyager Fleet Energy Storage by up to 56%, Bringing Eagle and Falcon to 2.025 MWh](https://biopharmsignal.com/news/LIXT/nomad-increases-voyager-fleet-energy-storage-by-up-to-56-bringing-eagle-and-falc-4f686804) — Source: Lixte Biotechnology Holdings
- 2026-07-06 12:30 EST — [LIXTE Completes Corporate Name Change to NOMAD Power Solutions, Inc.; To Begin Trading Under New Nasdaq Symbol NMAD](https://biopharmsignal.com/news/LIXT/lixte-completes-corporate-name-change-to-nomad-power-solutions-inc-to-begin-trad-1e7a1571) — Source: Lixte Biotechnology Holdings